<code id='6227770FEA'></code><style id='6227770FEA'></style>
    • <acronym id='6227770FEA'></acronym>
      <center id='6227770FEA'><center id='6227770FEA'><tfoot id='6227770FEA'></tfoot></center><abbr id='6227770FEA'><dir id='6227770FEA'><tfoot id='6227770FEA'></tfoot><noframes id='6227770FEA'>

    • <optgroup id='6227770FEA'><strike id='6227770FEA'><sup id='6227770FEA'></sup></strike><code id='6227770FEA'></code></optgroup>
        1. <b id='6227770FEA'><label id='6227770FEA'><select id='6227770FEA'><dt id='6227770FEA'><span id='6227770FEA'></span></dt></select></label></b><u id='6227770FEA'></u>
          <i id='6227770FEA'><strike id='6227770FEA'><tt id='6227770FEA'><pre id='6227770FEA'></pre></tt></strike></i>

          explore

          explore

          author:fashion    Page View:66
          dose of methadone
          A dose of methadone Kevin D. Liles/AP

          The federal government is reforming methadone care for the first time in over two decades. But how far do the changes actually go?

          To many methadone clinics, the Biden administration’s recent refresh of the rules governing opioid treatment programs represents an unprecedented opportunity to offer care that is more compassionate and responsive to patients’ needs. To many patient advocates, however, it simply nibbles around the edges. 

          advertisement

          The reality is likely somewhere in between: It will depend, in large part, on whether state-level regulators embrace the changes, and whether individual clinics actually implement them. In reform-oriented states, and at patient-centered clinics, the new rules could make a world of difference for people seeking addiction treatment. 

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Trump demands the U.S. pay no more for drugs than other countries … again
          Trump demands the U.S. pay no more for drugs than other countries … again

          EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

          read more
          Pfizer, Moderna say biotech, pharma drug development is a sprint
          Pfizer, Moderna say biotech, pharma drug development is a sprint

          Fromlefttoright,STAT'sDamianGarde;MikaelDolsten,chiefscientificofficerofPfizerresearchanddevelopment

          read more
          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more

          Diabetes management: Digital health tools fall short, study says

          AdobeThelastdecadehasseenbillionsofdollarsflowintodigitalhealthcompaniesthatpromisetoimproveoutcomes